4D Pharma PLC Warrant
LBPSW
LBPSW was delisted on the 29th of June, 2022.
4 hedge funds and large institutions have $6K invested in 4D Pharma PLC Warrant in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 2 closing their positions.
33% less funds holding
Funds holding: 6 → 4 (-2)
97% less capital invested
Capital invested by funds: $202K → $6K (-$196K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFM
Boothbay Fund Management
New York
|
-$133K |
| 2 |
HF
HRT Financial
New York
|
-$4.83K |
| 3 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$1.99K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AA
1
AQR Arbitrage
Greenwich,
Connecticut
| $2K | -$1.99K | -7,373 | -12% |
|
|
YCM
2
Yakira Capital Management
Westport,
Connecticut
| $2K | – | – | – |
|
|
HF
3
HRT Financial
New York
| $1K | -$4.83K | -17,944 | -31% |
|
4
Walleye Capital
New York
| $1K | – | – | – |
|
|
BFM
5
Boothbay Fund Management
New York
| – | -$133K | -27,625 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$1K | -3,130 | Closed |
|
LBPSW Hedge Fund Activity: Q2 2022 in Review
4 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in 4D Pharma PLC Warrant (LBPSW) for Q2 2022, worth a combined $6K — down 97% from $202K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of LBPSW and 0 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 0 added.
The largest seller was Boothbay Fund Management, exiting entirely with an estimated $133K sold.
- 4 institutional investors held 4D Pharma PLC Warrant (LBPSW) as of Q2 2022, down from 6 in Q1 2022.
- Funds reported $6K of 4D Pharma PLC Warrant stock for Q2 2022, down 97% quarter-over-quarter.
- 0 funds opened new 4D Pharma PLC Warrant positions in Q2 2022 and 2 closed out, a net change of -2 holders.
- The largest 4D Pharma PLC Warrant seller in Q2 2022 was Boothbay Fund Management, an estimated $133K sold.
Based on aggregated 13F filings for Q2 2022.